Research Study Seeks ALS Patients

If you or someone you know experience episodes of uncontrollable laughing and/or crying, you may be eligible for a clinical study now underway to find a treatment for this condition.

A clinical research trial is actively enrolling patients to evaluate the efficacy and safety of a targeted treatment known as AVP-923. The trial is recruiting patients with ALS and other neurological disorders who have pseudobulbar affect, a condition characterized by episodes of uncontrollable laughing and/or crying. An estimated 50 percent of ALS patients suffer from pseudobulbar affect.

 To determine if you or someone you know is eligible for the study, please call Coordinated Clinical Research at 858-455-5463

Participants Must:

1. Be between 18 and 80 years of age
2. Meet all trial criteria

You can sign up for this trial here!